The advertisement promotes Nucala (mepolizumab) as a treatment option for chronic rhinosinusitis with nasal polyps in adults who have not responded adequately to nasal corticosteroids, while also providing important safety information.
Creative Information
| CID: | c7d6bb4c-1756-4ce3-b575-bf5ef3840fa4 |
| CRID: | 82_2108-972119 |
| Domain: | nucalahcp.com |
| Seat: | PP |
| Size: | 728x90 |
| Bid: | $0.02 |
| Timestamp: | 11/26/2025, 9:13:37 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/26/2025, 9:37:36 PM | 5.20s | |
| adomain_analysis | success | 11/26/2025, 11:09:56 PM | 3.14s | |
| adomain_capture | success | 11/26/2025, 11:09:53 PM | 0.13s | |
| ad_render | success | 11/26/2025, 9:37:31 PM | 23.28s | |
| brand_mapping | success | 11/26/2025, 9:13:37 PM | 0.09s | |
Analysis Results
Ad Format: banner
Brands: NUCALA
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 766.60 KB | ||||||||||||||||||||||
| Render Time: | 7.67 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 766.68 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives
